<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2022.854989</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>
<italic>Lacticaseibacillus rhamnosus</italic> GG Counteracts Rotavirus-Induced Ion Secretion and Enterocyte Damage by Inhibiting Oxidative Stress and Apoptosis Through Specific Effects of Living and Postbiotic Preparations</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Buccigrossi</surname>
<given-names>Vittoria</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/1645567"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Poeta</surname>
<given-names>Marco</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/749498"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cioffi</surname>
<given-names>Valentina</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/1727432"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Terranova</surname>
<given-names>Sara</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/1727388"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nunziata</surname>
<given-names>Francesco</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/1360852"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lo Vecchio</surname>
<given-names>Andrea</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/1234659"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Guarino</surname>
<given-names>Alfredo</given-names>
</name>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/884010"/>
</contrib>
</contrib-group>
<aff id="aff1">
<institution>Department of Translational Medical Science, Section of Pediatrics, University of Naples Federico II</institution>, <addr-line>Naples</addr-line>, <country>Italy</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Pedro Gutierrez-Castrellon, Hospital General Dr. Manuel Gea Gonzalez, Mexico</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Ener Cagri Dinleyici, Eski&#x15f;ehir Osmangazi University, Turkey; Metehan Ozen, Ac&#x131;badem University, Turkey</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Alfredo Guarino, <email xlink:href="mailto:alfguari@unina.it">alfguari@unina.it</email>
</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Microbiome in Health and Disease, a section of the journal Frontiers in Cellular and Infection Microbiology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>29</day>
<month>03</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>12</volume>
<elocation-id>854989</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>01</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>03</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Buccigrossi, Poeta, Cioffi, Terranova, Nunziata, Lo Vecchio and Guarino</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Buccigrossi, Poeta, Cioffi, Terranova, Nunziata, Lo Vecchio and Guarino</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Administration of <italic>Lacticaseibacillus rhamnosus</italic> GG (LGG) to children with gastroenteritis is recommended by universal guidelines. Rotavirus (RV) causes diarrhea through combined cytotoxic and enterotoxic effects. Aim of this study was to evaluate the mechanisms of efficacy of LGG in an <italic>in-vitro</italic> model of RV diarrhea in its viable form (LGG) and conditioned medium (mLGG).</p>
</sec>
<sec>
<title>Methods</title>
<p>Ion secretion corresponding to the NSP4 enterotoxic effect, was evaluated by short circuit current (<italic>Isc</italic>) and the cytotoxic effect by transepithelial electrical resistance (TEER) in Ussing chambers, upon exposure to RV in Caco-2 enterocyte monolayers treated or not with living probiotic or its culture supernatant. Mechanisms of enterotoxic and cytotoxic damage were evaluated including oxidative stress measured by reactive&#xa0;oxygen species, apoptosis evaluated by DAPI and nuclear staining, NFk&#x3b2;&#xa0;immunofluorescence.</p>
</sec>
<sec>
<title>Results</title>
<p>RV induced <italic>Isc</italic> increase and TEER decrease, respectively indicating ion secretion and epithelial damage, the two established pathways of diarrhea. Both probiotic preparations reduced both diarrheal effects, but their potency was different. Live LGG was equally effective on both enterotoxic and cytotoxic effect whereas mLGG was highly effective on ion secretion and showed minimal protective effects on cytoskeleton, apoptosis and NFk&#x3b2;.</p>
</sec>
<sec>
<title>Conclusions</title>
<p>LGG counteracts RV-induced diarrhea by inhibiting both cytotoxic and enterotoxic pathogenic mechanisms. Namely, LGG inhibits chloride secretion by specific moieties secreted in the medium with a direct pharmacologic-like action. This is considered a postbiotic effect. Subsequently, live bacteria exert a probiotic effect protecting the enterocyte structure.</p>
</sec>
</abstract>
<kwd-group>
<kwd>rotavirus</kwd>
<kwd>
<italic>Lacticaseibacillus rhamnosus</italic> GG</kwd>
<kwd>gastroenteritis</kwd>
<kwd>diarrhea</kwd>
<kwd>enterocyte damage</kwd>
<kwd>oxidative stress</kwd>
<kwd>probiotics</kwd>
<kwd>postbiotics</kwd>
</kwd-group>
<counts>
<fig-count count="5"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="39"/>
<page-count count="9"/>
<word-count count="4027"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Specific probiotics have been recommended as adjunctive treatment of gastroenteritis by several guidelines all over the world (<xref ref-type="bibr" rid="B19">Guarino et&#xa0;al., 2018</xref>). Many clinical trials showed that diarrhea is rapidly reduced upon administration of <italic>Lacticaseibacillus rhamnosus</italic> GG (LGG), and the effects are already observed within hours after the onset of therapy (<xref ref-type="bibr" rid="B18">Guarino et&#xa0;al., 2015</xref>). However, the mechanisms of action of LGG are not entirely clear. An established long-term effect by LGG is the restoration of microbiota in children. This was supported by several papers in healthy subjects (<xref ref-type="bibr" rid="B8">Cox et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B34">Rauch and Lynch, 2010</xref>) and in cystic fibrosis children (<xref ref-type="bibr" rid="B2">Bruzzese et&#xa0;al., 2014</xref>). However, this effect does not explain the rapid efficacy of LGG on diarrhea, which is already observed within hours after administration.</p>
<p>Rotavirus (RV) infection is the most frequent and severe form of acute gastroenteritis in infants and children worldwide (<xref ref-type="bibr" rid="B22">Lo Vecchio et&#xa0;al., 2017</xref>). RV severity is related to a combination of time-related mechanisms leading to secretory and osmotic diarrhea through a sequence of molecular events (<xref ref-type="bibr" rid="B9">De Marco et&#xa0;al., 2009</xref>). In the early phase of infection, RV directly induces active chloride and water secretion from the enterocyte into the intestinal lumen through the enterotoxic effects of the non-structural viral protein NSP4. This increases intracellular Ca<sup>2+</sup> concentration which in turn triggers electrogenic chloride secretion (<xref ref-type="bibr" rid="B9">De Marco et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B26">Ousingsawat et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B3">Buccigrossi et&#xa0;al., 2014</xref>). Oxidative stress is a key mechanism involved in the enterotoxic effect induced by RV (<xref ref-type="bibr" rid="B3">Buccigrossi et&#xa0;al., 2014</xref>).</p>
<p>Following early ion secretion, RV infection results in severe damage to the structure of intestinal villi with cell death and subsequent disruption of epithelial integrity (<xref ref-type="bibr" rid="B23">Medici et&#xa0;al., 2011</xref>) whose clinical expression is osmotic diarrhea consequent to malabsorption of nutrients which triggers an increased passive flux of water into the intestinal lumen.</p>
<p>The key treatment of acute gastroenteritis in children is the administration of oral rehydration solution (ORS) (<xref ref-type="bibr" rid="B16">Guarino et&#xa0;al., 2014</xref>) but this neither shortens the duration of diarrhea nor reduces the frequency of stool output. Therefore, additional therapies are recommended in adjunct to ORS in order to reduce intensity and duration of the disease. Administration of selected probiotics, including LGG and <italic>Saccharomyces boulardii</italic>, is the main approach to achieve such effect (<xref ref-type="bibr" rid="B16">Guarino et&#xa0;al., 2014</xref>).</p>
<p>
<italic>In-vitro</italic> and <italic>in-vivo</italic> studies indicate that <italic>S. boulardii</italic> exerts its antidiarrheal effect acting on the resident microflora and inducing an anti-inflammatory effect (<xref ref-type="bibr" rid="B32">Pothoulakis, 2009</xref>). However its rapid antidiarrheal effect might be due to secreted molecules directly acting on intestinal epithelial cells inhibiting the secretive diarrhea through an anti-oxidant mechanism (<xref ref-type="bibr" rid="B3">Buccigrossi et&#xa0;al., 2014</xref>). This is defined as &#x201c;postbiotic effect&#x201d; (<xref ref-type="bibr" rid="B38">Tsilingiri and Rescigno, 2013</xref>) and was proposed for several bacteria (<xref ref-type="bibr" rid="B21">Levy et&#xa0;al., 2015</xref>), including LGG (<xref ref-type="bibr" rid="B6">Cicenia et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B15">Gao et&#xa0;al., 2019</xref>).</p>
<p>In clinical trials LGG reduces secretory diarrhea in very short time, measurable in hours. This suggests that neither changes in microflora (<xref ref-type="bibr" rid="B8">Cox et&#xa0;al., 2010</xref>) nor anti-inflammatory effect (<xref ref-type="bibr" rid="B27">Pagnini et&#xa0;al., 2018</xref>) are implicated with such the rapid efficacy. LGG directly interacts with intestinal epithelial cells but the exact mechanisms of diarrhea reduction it is not clear. In the present study, we investigated the effects of LGG in either form of living bacteria and LGG-conditioned medium on specific RV-induced enterotoxic and cytotoxic effect in our experimental model of human derived intestinal epithelium.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s2_1">
<title>Cell Line</title>
<p>Caco-2 cells (American Type Culture Collection, Middlesex, UK) were used as a model of mature and differentiated enterocytes. Cells were grown in high glucose DMEM with 10% fetal calf serum (FBS), 1% non-essential amino acids, 50 mg/ml streptomycin, 50mU/ml penicillin. The cells were grown for 15-18 days after confluence on polycarbonate Snapwell filters (pore size 0,4 micron) (Costar Italia, Milan, Italy).</p>
</sec>
<sec id="s2_2">
<title>Virus Strain and Infection Protocol</title>
<p>The infection of Caco-2 cell monolayers was performed with the simian rotavirus strain SA11 (RV) at a multiplicity of infection (MOI) of 25. RV activation was performed with 20 &#xb5;g/mL trypsin for 1 hour at 37&#xb0;C. Then, viral sample was added to the apical side of the Caco-2 cell monolayers for 1 hour at 37&#xb0;C, then the cells were rinsed 3 times and incubated in serum&#x2013;free medium for 1 hour. Then, Caco-2 cells were mounted in Ussing chamber system as described below. This model has been currently used to test the effects of antimicrobial molecules (<xref ref-type="bibr" rid="B3">Buccigrossi et&#xa0;al., 2014</xref>) and has become a standard tool for studying the direct effects of drugs and toxins in human intestinal epithelial cells. Cells were incubated with LGG in different conditions as described below before and after RV infection.</p>
</sec>
<sec id="s2_3">
<title>Preparation of <italic>Lacticaseibacillus</italic> Culture Supernatant</title>
<p>A preparation of LGG supernatant (6x10<sup>9</sup> u.f.c.). LGG were grown in Dulbecco<bold>&#x2019;</bold>s modified Eagle essential medium (DMEM; Life Technologies Italia, Monza, Italy) with a high glucose concentration (4.5 g/L); 10% fetal bovine serum (FBS, Life Technologies Italia, Monza, Italy) and 1% non-essential amino acids were added. LGG were cultured for 72 h at 42&#xb0;C. The cells-free culture supernatant (mLGG) was obtained by centrifugation and the subsequent passage through a 0.22 mm filter. The stock used in this study has a protein content of 1.5 mg/mL</p>
</sec>
<sec id="s2_4">
<title>Ion Transport Studies</title>
<p>The Ussing chamber system is used to evaluate ion transport in polarized cell monolayers, grown on permeable supports. Caco-2 cells were short-circuited by a voltage clamp in Ussing chambers (Physiological Instruments, San Diego, CA). Electrical parameters analyzed are: short circuit current [<italic>Isc</italic> represents the short circuit required to bring Vt to 0 mV expressed in &#xb5;A/cm<sup>2</sup>, epithelial membrane resistance expressed as tissue ionic conductance (G measured in mS/cm<sup>2</sup>) and, finally, transmembrane voltage (Vt, expressed in mV)]. Every 20 sec current pulses were passed across the epithelium and the current was measured and transepithelial resistance (R) was calculated.</p>
<p>
<italic>Isc</italic> is the parameter that is a measure of the secretory/absorptive result. The integrated response was calculated between 10 and 50 mins. In addition, the peak of <italic>Isc</italic> response obtained in the time period considered (after subtraction of baseline <italic>Isc</italic>; named &#x394; <italic>Isc</italic>) was used as a measure of the secretory/absorptive response. The proabsorptive effect is indicated as negative value of &#x394; <italic>Isc</italic> whereas the positive values indicate an active ion secretion. The maximal increase of <italic>Isc</italic> (&#x394; <italic>Isc</italic>) is considered the peak effect (<xref ref-type="bibr" rid="B4">Buccigrossi et&#xa0;al., 2020</xref>). Caco-2 cell monolayers were stimulated with LGG or mLGG 1 hour before RV infection and for the duration of the experiment.</p>
</sec>
<sec id="s2_5">
<title>Reactive Oxygen Species (ROS) Production Assay</title>
<p>DCFH-DA spectrofluorometry was used to measure ROS production in our model. DCFH-DA (20 &#xb5;M) was added for 30 minutes at 37&#xb0;C in the dark after stimulation. Intracellular ROS levels was measured in a fluorometer (Kontron Instruments, Japan). For DCF fluorescence imaging, Caco-2 cells were grown for 3 days on the cover glass, then fixed and permeabilized with paraformaldeyde 4% and Triton 0,2% for 30&#xa0;minutes at 4&#xb0;C. DCF-HA 20 &#xb5;M was added for 30 minutes at 37&#xb0;C in the dark. Fluorescence images from multiple fields were obtained using a Nikon Eclipse e 80i microscopy. The images were analyzed using NiS Elements D imaging software (Nikon Instruments Inc., NY, USA).</p>
</sec>
<sec id="s2_6">
<title>Glutathione Assay</title>
<p>GSH/GSSG ratio at intracellular level was measured by a fluorimetric assay kit (Biovision Milpitas, CA). The values were normalized for protein content and expressed as % of control.</p>
</sec>
<sec id="s2_7">
<title>Transepithelial Electrical Resistance Measurements</title>
<p>Transepithelial electrical resistance (TEER) of cell monolayers grown on filters was measured using a Millicel-ERS resistance monitoring apparatus (Millipore). The net TEER (in Ohms/cm<sup>2</sup>) was calculated by subtracting the background from the actual value and multiplying the value obtained by the area of the filter (4.9 cm<sup>2</sup>).</p>
</sec>
<sec id="s2_8">
<title>Immunofluorescence Methods</title>
<p>Actin staining: fixation and permeabilization was performed with 4% paraformaldehyde and 0.2% Triton X-100 for 30 min at + 4&#xb0;C. Cells were treated with 50 &#xb5;g/ml solution of Alexa Fluor 594-phalloidin (Sigma-Aldrich) for 40 min.</p>
<p>Occludin staining: cells were fixed by adding 100% methanol for 10 min at room temperature and probed with anti-occludin antibody (Abcam ab59720) over night at +4&#xb0;C. Bound antibody was detected with Alexa fluor 488 conjugated anti-rabbit IgG antibody (Invitrogen, A21206).</p>
<p>Immunofluorescence assay for NF-kB: Caco-2 cells were grown on the chambered cover glass for 3 days, fixed with 4% buffered paraformaldehyde (pH 7.4) for 30 minutes followed by blocking and permeabilization for 1 h in PBS with 1% BSA and 0.1% Triton X-100 at room temperature. Caco-2 cells were then incubated at 4&#xb0;C with anti-NFkB p65 antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) in a humidified chamber and incubated with a FITC-conjugated goat anti-rabbit antibody at room temperature and with Hoechst 33342 (10 &#xb5;g/mL) for 5 min.</p>
<p>For all immunofluorescence studies, slides were mounted with Vectashield Mounting Medium with DAPI (Vector laboratories, Ltd, UK). Fluorescence images from multiple fields were obtained using a Nikon Eclipse e 80i microscopy. The images were analyzed using NiS Elements D imaging software (Nikon Instruments Inc., NY, USA).</p>
</sec>
<sec id="s2_9">
<title>Caspase-3 Activity Assay</title>
<p>We used caspase-3 as a marker of apoptosis (<xref ref-type="bibr" rid="B14">Furuya-Kanamori et&#xa0;al., 2015</xref>). An apoptosis assay kit was used to determine caspase-3 activity, according to the manufacturer&#x2019;s instructions (Biovision, Mountain View, CA). Caspase-3 activity was investigated in Caco-2 cells by the release of the chromophore pNA after substrate cleavage. Modifications of caspase-3 activity were determined by comparing the sample optical density (OD) with the control.</p>
</sec>
<sec id="s2_10">
<title>Immunoblotting</title>
<p>Total cell lysates were obtained by homogenization of cell pellets in cold lysis buffer (20 mM Tris, pH 7.5 containing 300 mM sucrose, 60 mM KCl, 15 mM NaC1, 5% (v/v) glycerol, 2 mM EDTA, 1% (v/v) Triton X-100, 1 mM PMSF, 2 mg/ml aprotinin, 2 mg/ml leupeptin and 0.2% (w/v) deoxycholate) for 1 min at 4&#xb0;C and then sonication for 30 sec at 4&#xb0;C. Equal amounts of protein were separated on 10% (v/v) SDS-PAGE and transferred to a PVDF membrane (Millipore). The membrane was blocked with 5% (w/v) skim milk. Then, incubation with primary antibody followed by an HRP-conjugated secondary antibody were performed. Separated proteins were visualized with the ECL detection system (GE-Healthcare). The following antibodies were used for Western blot analysis: anti-caspase-3, anti-NFkB p65 and anti-Tubulin antibodies (Santa Cruz Biotechnology).</p>
</sec>
<sec id="s2_11">
<title>Statistical Analysis</title>
<p>GraphPad Prism Software (San Diego, CA) was used to evaluate the two-tailed unpaired Student t test. In addition, a 2-tailed paired Student t test to evaluate statistical significance. The alpha value of 0.05 was set for statistical significance. p-values for each analysis are indicated in figure legends.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>Effects of LGG on RV-Induced Enterotoxic Effect</title>
<p>As previously reported in the basic model of Caco-2 cells, RV-induced chloride secretion is NSP4-dependent and involves oxidative stress (<xref ref-type="bibr" rid="B9">De Marco et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B3">Buccigrossi et&#xa0;al., 2014</xref>). To investigate the effects of LGG on RV-induced chloride secretion, we preincubated Caco-2 cell monolayers with living LGG (LGG) or the conditioned medium from LGG (mLGG) before RV infection. In Ussing chamber experiments, the magnitude of short circuit current (&#x394;<italic>Isc</italic>), which reflects the intensity of RV-induced chloride secretion, was significantly reduced by LGG and completely abolished by mLGG (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>). In the latter condition, a pro-absorptive effect was also observed. LGG and mLGG alone did not induce <italic>Isc</italic> changes (data not shown).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Effects of LGG on enterotoxic effect induced by RV. Caco-2 cell monolayers were infected with RV and preincubated with LGG or mLGG as described in the Methods and then, the short-circuit current (<italic>I</italic>sc) was evaluated in Ussing chambers togheter with unifected cells (CTRL). *p &lt; 0.05 vs CTRL; <sup>#</sup>p &lt; 0.05 vs RV; <sup>&#xa7;</sup>p &lt; 0.05 vs LGG+RV.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-12-854989-g001.tif"/>
</fig>
<p>Since RV-induced enterotoxic damage is oxidative stress-dependent (<xref ref-type="bibr" rid="B9">De Marco et&#xa0;al., 2009</xref>), the redox state was evaluated in Caco-2 cells infected with RV following preincubation with LGG or mLGG. RV induced ROS production that was completely inhibited by LGG and mLGG at the same levels of N-acetylcysteine (NAC), a potent antioxidant (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2A, B</bold>
</xref>). To evaluate the role of antioxidant defenses, we determined the levels of reduced and oxidized glutathione (GSH/GSSG ratio) in RV-infected Caco-2 cells following preincubation with LGG or mLGG. The GSH/GSSG ratio was maintained when RV-infected cells were exposed to LGG or mLGG (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>). In all experiments, NAC was used as antioxidant factor. Our results indicated that NAC preincubation results in an anti-oxidant preventive effect on ROS production and GSH/GSSG ratio (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Effect of LGG on oxidative stress induced by RV. <bold>(A)</bold> ROS production was evaluated in Caco-2 cell monolayers infected with RV preincubated with LGG or mLGG as described in the Methods. [*p&lt; 0.05 vs CTRL; #p&lt;0,05 vs RV]. <bold>(B)</bold> Caco2 cells were infected with RV following preincubation in the absence of LGG or mLGG and the fluorescence of the ROS probe was evaluated one hour following infection. Magnification: 400X <bold>(C)</bold> Caco-2 cells monolayers were infected with RV and glutathione was evaluated one hour following infection and levels of GSH (gray) and GSSG (white) were measured. LGG and mLGG preincubation are present during the activation phase of the virus as described in the Methods. [*p &lt; 0.05 vs control; <sup>#</sup>p &lt; 0.05 vs RV]. In all experiments, NAC was used as antioxidant factor.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-12-854989-g002.tif"/>
</fig>
<p>Since NSP4 induces chloride secretion by Ca<sup>2+</sup> pathways, we investigated the role of Ca<sup>2+</sup> in our model. Thapsigargin, an inhibitor of the ER Ca<sup>2+</sup>-ATPase (<xref ref-type="bibr" rid="B24">Michelangeli et&#xa0;al., 1995</xref>; <xref ref-type="bibr" rid="B10">D&#xed;az et&#xa0;al., 2012</xref>), selectively depletes the endoplasmic reticulum Ca<sup>2+</sup> stores. Thapsigargin induced an increase in <italic>Isc</italic> (0.9 &#xb1; 0.5 vs 16.1&#xa0;&#xb1; 1.5; p&lt;0.05) but no difference was found when cells were preincubated with LGG or mLGG (control 16.1 &#xb1; 1.5; LGG 14.9&#xa0;&#xb1; 0.9; mLGG 13.7 &#xb1; 1.2; p=NS) suggesting that the mechanism of action is upstream Ca<sup>2+</sup> release.</p>
</sec>
<sec id="s3_2">
<title>Effects of LGG on RV-Induced Cytotoxic Damage</title>
<p>To investigate LGG effects on RV-induced epithelial damage, RV infected Caco-2 cell monolayers were exposed to LGG or mLGG and intestinal epithelial integrity was evaluated.</p>
<p>Occludin staining looked like a network in untreated and well differentiated cells whereas RV induces a major break of the junctions between the cells. The presence of LGG, but not mLGG, preserved cells from RV-induced damage (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). This effect was also confirmed by transepithelial resistance data. RV induced a strong decrease of TEER that was significantly prevented by LGG but not by mLGG (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>). Finally, actin staining also showed that LGG living microorganisms but not mLGG, protects cells by cytoskeleton destruction induced by RV (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Effect of LGG on cytotoxic damage induced by RV. <bold>(A)</bold> Occludin, as marker of tight junction structure, was evaluated with immunofluorescence in Caco-2 cell monolayers infected with RV preincubated with LGG or mLGG as described in the Methods Magnification: 400X. <bold>(B)</bold> Caco-2 cells monolayers were infected with RV following preincubation in the of LGG or mLGG and transepithelial electrical resistence (TEER) was evaluated as described in the Methods together with uninfected cells; [*p &lt; 0.05 vs CTRL; <sup>#</sup>p &lt; 0.05 vs RV]. <bold>(C)</bold> Phalloidin, as marker of cytoskeleton architecture, was used with immunofluorescence in Caco-2 cell monolayers infected with RV preincubated with LGG or mLGG as described in the Methods Magnification: 400X.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-12-854989-g003.tif"/>
</fig>
</sec>
<sec id="s3_3">
<title>Effects of LGG on RV-Induced Apoptosis</title>
<p>Apoptosis was evaluated by nuclei staining and caspase activation. RV infected cells have smaller nuclei with irregular edges (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>). Because DAPI staining is an indirect marker of apoptosis, caspase-3 activation was evaluated. We observed that RV infection increases caspase-3 activity suggesting that apoptosis is one of the mechanisms of cell damage. Both LGG and mLGG significantly reduced apoptosis induced by RV with a similar efficacy (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4A, B</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Effect of LGG on apoptosis induced by RV. <bold>(A)</bold> Apoptotic nuclei were evaluated in Caco-2 cell monolayers infected with RV preincubated with LGG or mLGG as described in the Methods Magnification: 400X. <bold>(B)</bold> Caco2 cells were infected with RV following preincubation in the absence of LGG or mLGG and caspase-3 activity as apoptotic marker was evaluated as described in Methds [*p &lt; 0.05 vs CTRL; <sup>#</sup>p &lt; 0.05 vs RV].</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-12-854989-g004.tif"/>
</fig>
</sec>
<sec id="s3_4">
<title>Effects of LGG on RV-Induced NF-kB Activation</title>
<p>NF-kB activation has a key role in intestinal epithelial permeability (<xref ref-type="bibr" rid="B11">Dominguez et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B39">Yang et&#xa0;al., 2014</xref>) as well as in infections (<xref ref-type="bibr" rid="B37">Santoro et&#xa0;al., 2003</xref>), including RV (<xref ref-type="bibr" rid="B35">Rossen et&#xa0;al., 2004</xref>) and SARS-CoV-2 (<xref ref-type="bibr" rid="B31">Poeta et&#xa0;al., 2021</xref>) infections. NF-kB is found in the cytoplasm as an inactive factor, a heterodimer of p50 and p65 subunits bound with a member of the IkB inhibitor protein family. Removal of IkB, induced by several stimuli, results in NF-kB activation through p65 phosphorylation and its translocation to the nucleus (<xref ref-type="bibr" rid="B5">Campbell and Perkins, 2006</xref>). To see whether NF-kB was activated in response to RV infection, we evaluated the levels of phospho-p65 and its nuclear localization in RV-infected Caco-2 cells.</p>
<p>As shown in <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>, the levels of phospho-p65 were increased in cell extracts following RV infection. We also observed p65 translocation from cytoplasm to the nucleus with immunofluorescence (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>). Phospho-p65 intracellular levels was inhibited in RV-infected cells exposed to LGG and mLGG with a similar efficacy (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>) and the nuclear translocation did not ensue (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Effect of LGG on RV-induced activation of NF-kB pathway in Caco-2 cells. <bold>(A)</bold> Activated NF-kB p65 subunit (upper panel) was evaluated in RV-infected Caco-2 cells with or without the addition of mLGG or LGG and compared to total p65 levels in a western blot experiment. <bold>(B)</bold> NF-kB p65 subunit was detected in RV-infected cells with or without the addition of mLGG or LGG with immunofluorescent method as described in &#x201c;Method&#x201d; section and nuclei were stained by Hoerst. Red arrows indicate the p65 nuclear localization. Data are representative of 3 separate experiments.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-12-854989-g005.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>Our data demonstrated that conditioned medium of LGG has a stronger effect than living microorganisms in reducing ion secretion induced by RV. In Ussing chamber system, living LGG significantly reduced <italic>Isc</italic> but its conditioned medium was much stronger and even reverted the ion flux toward a proabsorbitive condition. Both preparations significantly reduced oxidative stress which is the key mechanism of ionic secretion induced by RV at intestinal level (<xref ref-type="bibr" rid="B3">Buccigrossi et&#xa0;al., 2014</xref>). Our observations are in agreement with the results of a transcriptome analysis of a recent study, which showed the downregulation of genes related to oxidative stress in Caco-2 cells treated with living LGG (<xref ref-type="bibr" rid="B20">Hou et&#xa0;al., 2019</xref>).</p>
<p>The cytotoxic effect by RV is observed in the subsequent phase of infection (<xref ref-type="bibr" rid="B9">De Marco et&#xa0;al., 2009</xref>). We evaluated the effects of LGG and mLGG by different approaches. Immunofluorescence technique allowed us to evaluate the tight junctions and cytoskeleton integrity by occludin and actin staining. We observed that both LGG and mLGG protect enterocytes from RV damage but the former preparation was more effective. Because the transepithelial resistance provides a sensitive quantitative measure of the effect, we could obtain compelling proof that living LGG more effectively counteracts cell damage than mLGG. However, both forms completely inhibited apoptosis and p65 activation and its translocation from cytoplasm to the nucleus thereby hampering RV pathological effects. This is in agreement with other studies in which LGG counteracted intestinal inflammation (<xref ref-type="bibr" rid="B13">Fong et&#xa0;al., 2016</xref>).</p>
<p>Probiotics exert antidiarrheal effects through several mechanisms of actions, including the microbiota restoration, the secretion of antimicrobial substances, the competitive exclusion of pathogens (<xref ref-type="bibr" rid="B30">Plaza-Diaz et&#xa0;al., 2020</xref>) and the modulation of the local and systemic immune response (<xref ref-type="bibr" rid="B29">Plaza-D&#xed;az et&#xa0;al., 2018</xref>). Although these mechanisms may contribute to the antidiarrheal effect of probiotics administration, they physiologically require hours or even days to establish (<xref ref-type="bibr" rid="B1">Amamoto et&#xa0;al., 2021</xref>). However, from a clinical point of view, we previously observed that LGG administration reduces the duration of diarrhea in children with RV infection (<xref ref-type="bibr" rid="B17">Guarino et&#xa0;al., 1997</xref>) and the effect on stool outputs is observed as early as after a few hours from its administration. This effect observed over hours is not consistent with a modification of intestinal microbiota and is more likely consistent with a &#x201c;pharmacological&#x201d; action.</p>
<p>In the last 10 years, the term &#x201c;postbiotic&#x201d; caught interest of researchers and companies (<xref ref-type="bibr" rid="B7">Collado et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B12">Dunand et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B33">Rad et&#xa0;al., 2020</xref>), and, recently, the International Scientific Association of Probiotics and Prebiotics (ISAPP) defined postbiotics as &#x201c;preparations of inanimate microorganisms and/or their components that confers a health benefit on the host&#x201d; (<xref ref-type="bibr" rid="B36">Salminen et&#xa0;al., 2021</xref>). Compared with probiotics, products obtained from non-viable microorganisms are a promising alternative to improve health and counteract pathogens and drugs, being potentially &#x201c;pure&#x201d; and dosable. Although probiotics have an undisputed role in the prevention and treatment of several pathological conditions, there is a risk of living bacterial translocation from gut lumen to bloodstream particularly in leaky gut conditions. This implicates risk of severe clinical risk of using probiotics in fragile patients such as those with Necrotizing Enterocolitis (NEC) (<xref ref-type="bibr" rid="B25">Neu, 2011</xref>; <xref ref-type="bibr" rid="B28">Pietz, 2011</xref>). Postbiotics might provide a safer alternative being microbial components that act as pharmacologic-like molecules in terms of absorption, metabolism and excretion. In addition, higher stability and easier to standardize treatment beg key advantages for clinical use (<xref ref-type="bibr" rid="B33">Rad et&#xa0;al., 2020</xref>).</p>
<p>In our experimental model, the differential efficacy between living LGG and mLGG could explain the different mechanisms of actions. Specifically, secretory diarrhea could benefit from an effect mediated by molecules secreted by the probiotic with a &#x201c;pharmacological&#x201d; mechanism, similarly to what happens with &#x201c;postbiotics&#x201d; (<xref ref-type="bibr" rid="B36">Salminen et&#xa0;al., 2021</xref>). This would explain the rapidity of effectiveness observed in clinical trials. In a subsequent phase, the living probiotic protects against epithelial damage induced by RV infection with a typical probiotic mechanism, interacting with the enterocyte in a more dynamic modality.</p>
<p>The main limitation of our experimental model is that it represents a simplification of what occurs in human gut environment, which is common to all <italic>in vitro</italic> models. Further analysis will be needed to confirm our findings in <italic>ex vivo</italic> and <italic>in vivo</italic> models. In conclusion, our study contributes to a better understanding of the mechanism of efficacy of LGG in RV-induced diarrhea and contributes to identify the target mechanisms which may exploit a battery of molecules.</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data Availability Statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s6" sec-type="author-contributions">
<title>Author Contributions</title>
<p>VB and AG conceived and designed the experiments. VC and ST performed the experiments. VB and AG supervised the research project. VB, MP, VC, FN, and AL analyzed the data. VB and AG wrote the paper. All authors read and approved the final manuscript.</p>
</sec>
<sec id="s7" sec-type="funding-information">
<title>Funding</title>
<p>The study was in part supported by <italic>Dicofarm</italic> S.p.A. The funding sponsors had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results.</p>
</sec>
<sec id="s8" sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>The study was in part supported by Dicofarm S.p.A. The funding sponsors had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results. All authors declare no other competing interests.</p>
</sec>
<sec id="s9" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amamoto</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Shimamoto</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Park</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Matsumoto</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Shimizu</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Katto</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Yearly Changes in the Composition of Gut Microbiota in the Elderly, and the Effect of Lactobacilli Intake on These Changes</article-title>. <source>Sci. Rep.</source> <volume>11</volume>, <fpage>12765</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-021-91917-6</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bruzzese</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Callegari</surname> <given-names>M. L.</given-names>
</name>
<name>
<surname>Raia</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Viscovo</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Scotto</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Ferrari</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Disrupted Intestinal Microbiota and Intestinal Inflammation in Children With Cystic Fibrosis and Its Restoration With Lactobacillus GG: A&#xa0;Randomised Clinical Trial</article-title>. <source>PloS One</source> <volume>9</volume>, <fpage>e87796</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0087796</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buccigrossi</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Laudiero</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Russo</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Miele</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Sofia</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Monini</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Chloride Secretion Induced by Rotavirus Is Oxidative Stress-Dependent and Inhibited by Saccharomyces Boulardii in Human Enterocytes</article-title>. <source>PloS One</source> <volume>9</volume>, <fpage>e99830</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0099830</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buccigrossi</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Lo Vecchio</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Bruzzese</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Russo</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Marano</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Terranova</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Potency of Oral Rehydration Solution in Inducing Fluid Absorption Is Related to Glucose Concentration</article-title>. <source>Sci. Rep.</source> <volume>10</volume>, <elocation-id>7803</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-020-64818-3</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Campbell</surname> <given-names>K. J.</given-names>
</name>
<name>
<surname>Perkins</surname> <given-names>N. D.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Regulation of NF-kappaB Function</article-title>. <source>Biochem. Soc Symp.</source> <volume>73</volume>, <fpage>165</fpage>&#x2013;<lpage>180</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1042/bss0730165</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cicenia</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Santangelo</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Gambardella</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Pallotta</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Iebba</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Scirocco</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Protective Role of Postbiotic Mediators Secreted by Lactobacillus Rhamnosus GG Versus Lipopolysaccharide-Induced Damage in Human Colonic Smooth Muscle Cells</article-title>. <source>J. Clin. Gastroenterol.</source> <volume>50</volume>, <fpage>S140</fpage>&#x2013;<lpage>S144</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/MCG.0000000000000681</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Collado</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Vinderola</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Salminen</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Postbiotics: Facts and Open Questions. A Position Paper on the Need for a Consensus Definition</article-title>. <source>Benef. Microbes</source> <volume>10</volume>, <fpage>711</fpage>&#x2013;<lpage>719</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3920/BM2019.0015</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cox</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>Y. J.</given-names>
</name>
<name>
<surname>Fujimura</surname> <given-names>K. E.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>J. T.</given-names>
</name>
<name>
<surname>McKean</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Boushey</surname> <given-names>H. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>Lactobacillus Casei Abundance Is Associated With Profound Shifts in the Infant Gut Microbiome</article-title>. <source>PloS One</source> <volume>5</volume>, <fpage>e8745</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0008745</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Marco</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Bracale</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Buccigrossi</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Bruzzese</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Canani</surname> <given-names>R. B.</given-names>
</name>
<name>
<surname>Polito</surname> <given-names>G.</given-names>
</name>
<etal/>
</person-group>. (<year>2009</year>). <article-title>Rotavirus Induces a Biphasic Enterotoxic and Cytotoxic Response in Human-Derived Intestinal Enterocytes, Which Is Inhibited by Human Immunoglobulins</article-title>. <source>J. Infect. Dis.</source> <volume>200</volume>, <fpage>813</fpage>&#x2013;<lpage>819</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1086/605125</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>D&#xed;az</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Pe&#xf1;a</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Aristimu&#xf1;o</surname> <given-names>O. C.</given-names>
</name>
<name>
<surname>Matteo</surname> <given-names>L.</given-names>
</name>
<name>
<surname>De Agrela</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Chemello</surname> <given-names>M. E.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>Dissecting the Ca 2+ Entry Pathways Induced by Rotavirus Infection and NSP4-EGFP Expression in Cos-7 Cells</article-title>. <source>Virus Res.</source> <volume>167</volume>, <fpage>285</fpage>&#x2013;<lpage>296</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.virusres.2012.05.012</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dominguez</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Samocha</surname> <given-names>A. J.</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Burd</surname> <given-names>E. M.</given-names>
</name>
<name>
<surname>Farris</surname> <given-names>A. B.</given-names>
</name>
<name>
<surname>Coopersmith</surname> <given-names>C. M.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Inhibition of Ikk&#x3b2; in Enterocytes Exacerbates Sepsis-Induced Intestinal Injury and Worsens Mortality</article-title>. <source>Crit. Care Med.</source> <volume>41</volume>, <fpage>e275</fpage>&#x2013;<lpage>e285</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/CCM.0b013e31828a44ed</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dunand</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Burns</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Binetti</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Bergamini</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Peralta</surname> <given-names>G. H.</given-names>
</name>
<name>
<surname>Forzani</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Postbiotics Produced at Laboratory and Industrial Level as Potential Functional Food Ingredients With the Capacity to Protect Mice Against Salmonella Infection</article-title>. <source>J. Appl. Microbiol.</source> <volume>127</volume>, <fpage>219</fpage>&#x2013;<lpage>229</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jam.14276</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fong</surname> <given-names>F. L. Y.</given-names>
</name>
<name>
<surname>Shah</surname> <given-names>N. P.</given-names>
</name>
<name>
<surname>Kirjavainen</surname> <given-names>P.</given-names>
</name>
<name>
<surname>El-Nezami</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Mechanism of Action of Probiotic Bacteria on Intestinal and Systemic Immunities and Antigen-Presenting Cells</article-title>. <source>Int. Rev. Immunol.</source> <volume>35</volume>, <fpage>179</fpage>&#x2013;<lpage>188</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3109/08830185.2015.1096937</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Furuya-Kanamori</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Stone</surname> <given-names>J. C.</given-names>
</name>
<name>
<surname>Clark</surname> <given-names>J.</given-names>
</name>
<name>
<surname>McKenzie</surname> <given-names>S. J.</given-names>
</name>
<name>
<surname>Yakob</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Paterson</surname> <given-names>D. L.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Comorbidities, Exposure to Medications, and the Risk of Community-Acquired Clostridium Difficile Infection: A Systematic Review and Meta-Analysis</article-title>. <source>Infect. Control Hosp. Epidemiol.</source> <volume>36</volume>, <fpage>132</fpage>&#x2013;<lpage>141</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1017/ice.2014.39</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wan</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>A Novel Postbiotic From Lactobacillus Rhamnosus GG With a Beneficial Effect on Intestinal Barrier Function</article-title>. <source>Front. Microbiol.</source> <volume>10</volume>, <elocation-id>477</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2019.00477</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guarino</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Ashkenazi</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Gendrel</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Lo Vecchio</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Shamir</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Szajewska</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases Evidence-Based Guidelines for the Management of Acute Gastroenteritis in Children in Europe: Update 2014</article-title>. <source>J. Pediatr. Gastroenterol. Nutr.</source> <volume>59</volume>, <fpage>132</fpage>&#x2013;<lpage>152</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/MPG.0000000000000375</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guarino</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Berni Canani</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Spagnuolo</surname> <given-names>M. I.</given-names>
</name>
<name>
<surname>Albano</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Di Benedetto</surname> <given-names>L.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Oral Bacterial Therapy Reduces the Duration of Symptoms and of Viral Excretion in Children With Mild Diarrhea</article-title>. <source>J. Pediatr. Gastroenterol. Nutr.</source> <volume>25</volume>, <fpage>516</fpage>&#x2013;<lpage>519</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/00005176-199711000-00005</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guarino</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Guandalini</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Lo Vecchio</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Probiotics for Prevention and Treatment of Diarrhea</article-title>. <source>J. Clin. Gastroenterol.</source> <volume>49</volume>, <fpage>S37</fpage>&#x2013;<lpage>S45</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/MCG.0000000000000349</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guarino</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Lo Vecchio</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Dias</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Berkley</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Boey</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Bruzzese</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Universal Recommendations for the Management of Acute Diarrhea in Nonmalnourished Children</article-title>. <source>J. Pediatr. Gastroenterol. Nutr.</source> <volume>67</volume>, <fpage>586</fpage>&#x2013;<lpage>593</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/MPG.0000000000002053</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hou</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Man</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Transcriptomic Responses 374 of Caco-2 Cells to Lactobacillus Rhamnosus GG and Lactobacillus Plantarum J26 Against 375 Oxidative Stress</article-title>. <source>J. Dairy Sci.</source> <volume>102</volume>, <fpage>7684</fpage>&#x2013;<lpage>7696</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3168/jds.2019-16332</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levy</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Thaiss</surname> <given-names>C. A.</given-names>
</name>
<name>
<surname>Zeevi</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Dohnalov&#xe1;</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Zilberman-Schapira</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Mahdi</surname> <given-names>J. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Microbiota-Modulated Metabolites Shape the Intestinal Microenvironment by Regulating NLRP6 Inflammasome Signaling</article-title>. <source>Cell</source> <volume>163</volume>, <fpage>1428</fpage>&#x2013;<lpage>1443</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2015.10.048</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lo Vecchio</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Liguoro</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Dias</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Berkley</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Boey</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Cohen</surname> <given-names>M. B.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Rotavirus Immunization: Global Coverage and Local Barriers for Implementation</article-title>. <source>Vaccine</source> <volume>35</volume>, <fpage>1637</fpage>&#x2013;<lpage>1644</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.vaccine.2017.01.082</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Medici</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Abelli</surname> <given-names>L. A.</given-names>
</name>
<name>
<surname>Martinelli</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Corradi</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Dodi</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Tummolo</surname> <given-names>F.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>Clinical and Molecular Observations of Two Fatal Cases of Rotavirus-Associated Enteritis in Children in Italy</article-title>. <source>J. Clin. Microbiol.</source> <volume>49</volume>, <fpage>2733</fpage>&#x2013;<lpage>2739</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JCM.01358-10</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michelangeli</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Liprandi</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Chemello</surname> <given-names>M. E.</given-names>
</name>
<name>
<surname>Ciarlet</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>And Ruiz, M</article-title>
<article-title>Selective Depletion of Stored Calcium by Thapsigargin Blocks Rotavirus Maturation But Not the Cytopathic Effect</article-title>. <source>CJ. Virol.</source> <volume>69</volume>, <fpage>3838</fpage>&#x2013;<lpage>3847</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/jvi.69.6.3838-3847.1995</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neu</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Routine Probiotics for Premature Infants: Let&#x2019;s be Careful</article-title>! <source>J.&#xa0;Pediatr.</source> <volume>158</volume>, <fpage>672</fpage>&#x2013;<lpage>674</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jpeds.2010.11.028</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ousingsawat</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Mirza</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Roussa</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Schreiber</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Cook</surname> <given-names>D. I.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>Rotavirus Toxin NSP4 Induces Diarrhea by Activation of TMEM16A and Inhibition of Na+ Absorption</article-title>. <source>Pfl&#xfc;gers Arch. Eur. J. Physiol.</source> <volume>461</volume>, <fpage>579</fpage>&#x2013;<lpage>589</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00424-011-0947-0</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pagnini</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Corleto</surname> <given-names>V. D.</given-names>
</name>
<name>
<surname>Martorelli</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Lanini</surname> <given-names>C.</given-names>
</name>
<name>
<surname>D&#x2019;Ambra</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Di Giulio</surname> <given-names>E.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Mucosal Adhesion and Anti-Inflammatory Effects of Lactobacillus Rhamnosus GG in the Human Colonic Mucosa: A Proof-of-Concept Study</article-title>. <source>World J. Gastroenterol.</source> <volume>24</volume>, <fpage>4652</fpage>&#x2013;<lpage>4662</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3748/wjg.v24.i41.4652</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pietz</surname> <given-names>J. T.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>To NEC or Not to NEC: Routine Use of Probiotics for Premature Infants</article-title>. <source>J. Pediatr.</source> <volume>159</volume>, <fpage>520</fpage>&#x2013;<lpage>521</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jpeds.2011.04.018</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Plaza-D&#xed;az</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Ruiz-Ojeda</surname> <given-names>F. J.</given-names>
</name>
<name>
<surname>Gil-Campos</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Gil</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Immune-Mediated Mechanisms of Action of Probiotics and Synbiotics in Treating Pediatric Intestinal Diseases</article-title>. <source>Nutrients</source> <volume>10</volume>, <elocation-id>42</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu10010042</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Plaza-Diaz</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Ruiz-Ojeda</surname> <given-names>F. J.</given-names>
</name>
<name>
<surname>Gil-Campos</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Gil</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Mechanisms of Action of Probiotics</article-title>. <source>Adv. Nutr.</source> <volume>10</volume> (<supplement>suppl_1</supplement>), <fpage>S49</fpage>&#x2013;<lpage>S66</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/advances/nmy063</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poeta</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Cioffi</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Buccigrossi</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Nanayakkara</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Baggieri</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Peltrini</surname> <given-names>R.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Diosmectite Inhibits the Interaction Between SARS-CoV-2 and Human Enterocytes by Trapping Viral Particles, Thereby Preventing NF-kappaB Activation and CXCL10 Secretion</article-title>. <source>Sci. Rep.</source> <volume>11</volume>, <elocation-id>21725</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-021-01217-2</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pothoulakis</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Review Article: Anti-Inflammatory Mechanisms of Action of Saccharomyces Boulardii</article-title>. <source>Aliment. Pharmacol. Ther.</source> <volume>30</volume>, <fpage>826</fpage>&#x2013;<lpage>833</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-2036.2009.04102.x.Review</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rad</surname> <given-names>A. H.</given-names>
</name>
<name>
<surname>Maleki</surname> <given-names>L. A.</given-names>
</name>
<name>
<surname>Kafil</surname> <given-names>H. S.</given-names>
</name>
<name>
<surname>Zavoshti</surname> <given-names>H. F.</given-names>
</name>
<name>
<surname>Abbasi</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Postbiotics as Novel Health-Promoting Ingredients in Functional Foods</article-title>. <source>Heal. Promot. Perspect.</source> <volume>10</volume>, <fpage>3</fpage>&#x2013;<lpage>4</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.15171/hpp.2020.02</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rauch</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Lynch</surname> <given-names>S. V.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Probiotic Manipulation of the Gastrointestinal Microbiota</article-title>. <source>Gut Microbes</source> <volume>1</volume>, <fpage>335</fpage>&#x2013;<lpage>338</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4161/gmic.1.5.13169</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rossen</surname> <given-names>J. W. A.</given-names>
</name>
<name>
<surname>Bouma</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Raatgeep</surname> <given-names>R. H. C.</given-names>
</name>
<name>
<surname>B&#xfc;ller</surname> <given-names>H. A.</given-names>
</name>
<name>
<surname>Einerhand</surname> <given-names>A. W. C.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>And Bu, H</article-title>
<article-title>Inhibition of Cyclooxygenase Activity Reduces Rotavirus Infection at a Postbinding Step</article-title>. <source>AJ. Virol.</source> <volume>78</volume>, <fpage>9721</fpage>&#x2013;<lpage>9730</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JVI.78.18.9721-9730.2004</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salminen</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Collado</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Endo</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Hill</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Lebeer</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Quigley</surname> <given-names>E. M. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>The International Scientific Association of Probiotics and Prebiotics (ISAPP) Consensus Statement on the Definition and Scope of Postbiotics</article-title>. <source>Nat. Rev. Gastroenterol. Hepatol.</source> <volume>18</volume>, <fpage>649</fpage>&#x2013;<lpage>667</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41575-021-00440-6</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santoro</surname> <given-names>M. G.</given-names>
</name>
<name>
<surname>Rossi</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Amici</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>NF-kB and Virus Infection : Who Controls Whom</article-title>. <source>EMBO J.</source> <volume>22</volume>, <fpage>2552</fpage>&#x2013;<lpage>2560</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/emboj/cdg267</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsilingiri</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Rescigno</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Postbiotics: What Else</article-title>? <source>Benef. Microbes</source> <volume>4</volume>, <fpage>101</fpage>&#x2013;<lpage>107</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3920/BM2012.0046</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Xiao</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>X.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Interferon-&#x3b3;-Induced Intestinal Epithelial Barrier Dysfunction by NF-&#x3ba;b/HIF-1&#x3b1; Pathway</article-title>. <source>J. Interf. Cytokine Res.</source> <volume>34</volume>, <fpage>195</fpage>&#x2013;<lpage>203</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/jir.2013.0044</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>